Summary
The effect of antihypertensive treatment on blood-retinal barrier leakage of fluorescein in background retinopathy was studied in nine hypertensive Type 1 (insulin-dependent) diabetic patients suffering from nephropathy. The patients were investigated before and after 7 (3 to 13) months of treatment with captopril (n=8; 25 to 100 mg daily) and a diuretic, either frusemide (n=4; 80 to 200 mg daily) or bendrofluazide (n=2; 2.5 mg daily). Retinal function was assessed by fundus photography, fluorescein angiography, vitreous fluorometry, and renal function by glomerular filtration rate, and albuminuria. The antihypertensive treatment induced a significant reduction (p<0.05) in: blood pressure from 152/97±14/8 mmHg to 134/82±11/6 mmHg; blood-retinal barrier leakage of fluorescein from 2.4 ±1.1 to 1.4±0.5·10−7 cm/second; albuminuria from 1391 (range: 168–4852) μg/min to 793 (range: 35–2081) ug/min. Glomerular filtration rate declined from 88±15 to 78±23 ml·min−1·1.73 m2 (0.05<p<0.10). The metabolic control of the patients as reflected by their blood glucose and HbA1c levels remained stable during the study. Our study suggests that systemic blood pressure elevation contributes to the abnormal blood-retinal barrier permeability to fluorescein characteristically found in diabetic background retinopathy and that this abnormality can be reversed during antihypertensive treatment.
Article PDF
Similar content being viewed by others
References
Kohner EM, McLeod D, Marshall J (1982) Diabetic eye disease. In: Keen H, Jarrett J (eds) Complications of diabetes, 2nd edn. Edward Arnold, London, pp 19–108
Cunha-Vaz JG, Abreu JR, Campos AJ, Figo GM (1975) Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 59: 649–656
Lund-Andersen H, Krogsaa B, La Cour MN, Larsen J (1985) Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26: 698–710
Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L (1987) Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin dependent diabetic patients. Acta Ophthalmol 65: 686–692
Kohner EM, Plehwe WE, Sleightholm MA (1988) Does vitreous fluorophotometry reflect the severity of early diabetic retinopathy? ARVO 29: 260 (Abstract)
Krogsaa B, Lund-Andersen H, Parving H-H, Bjældager P (1983) The blood-retinal barrier permeability in essential hypertension. Acta Ophthalmol 61: 541–544
Kornerup T (1957) Blood pressure and diabetic retinopathy. Acta Ophthalmol 35: 163–174
West KM, Erdreich LJ, Stober JA (1980) A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29: 501–508
Knowler WC, Bennett PA, Ballintine EJ (1980) Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 302: 645–650
Klein R, Klein BEK, Moss SE (1985) A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age. Diabetes Care 8: 71–76
Janka HU, Rand LI, Warram JH, Krolewski AS (1988) Glycosylated haemoglobin and diastolic blood pressure are the major predictors of progression of background diabetic retinopathy in Type 1 (insulin-dependent) diabetes. Diabetologia 31: 504 A (Abstract)
Mogensen CE (1982) Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688
Parving H-H, Andersen AR, Smidt UM, Svendsen PA (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet I: 1175–1179
Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447
Parving H-H, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 297: 1086–1091
Brøchner-Mortensen J (1972) A simple method for determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271–274
Brøchner-Mortensen J, Rødbro P (1976) Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36: 35–45
Miles DW, Mogensen CE, Gundersen HJG (1970) Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26: 5–11
Larsen M, Loft S, Hommel E, Lund-Andersen H (1988) Fluorescein and fluorescein glucunide in plasma after intravenous injection of fluorescein. Acta Ophthalmol 66: 427–432
Lund-Andersen H, Krogsaa B, Jensen PK (1982) Fluorescein in human plasma in vivo. Acta Ophthalmol 60: 709–716
Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L (1986) The blood-retinal barrier permeability to fluorescein in normal subjects and in juvenile diabetics without retinopathy. Acta Ophthalmol 64: 173–179
Mortensen HB (1980) Quantitative determination of haemoglobin A1c by thin layer isoelectric focusing. J Chromatogr 182: 325–333
Lauritzen T, Frost-Larsen K, Svendsen PA, Larsen H-W, Deckert T, Christiansen JS, Parving H-H, Binder C, Nerup J, Deckert M, Larsen A, Lørup B, Bojsen J, Bech-Jansen L (1982) Effect of 6 month of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Lancet I: 121–124
Lund-Andersen H (1979) Transport of glucose from blood to brain. Physiol Rev 59: 305–352
Cunha-Vaz JG, Mota CC, Leite EC, Abreu JR, Ruas MA (1985) Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy. Arch Ophthalmol 103: 1307–1311
Paulson O, Jarden DB, Vorstrup S, Holm S, Godtfredsen J (1986) Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest 16: 124–132
Sinclair SH, Graunvald JE, Riva C, Braunstein SL, Nichols CW, Schwartz S (1982) Retinal vascular autoregulation in diabetes mellitus. Ophthalmology 89: 748–750
Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA (1982) Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949
Hostetter TH, Troy JL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes. Kidney Int 19: 410–415
Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H (1986) Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490–495
Korthuis RJ, Pitts VH, Granger DN (1987) Intestinal capillary filtration in experimental diabetes mellitus. Am J Physiol 253: G20-G25
Rand LI, Krolewski AS, Aiello LM, Warram JA, Baker RS, Maki T (1985) Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 313: 1433–1438
Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS (1984) Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27: 547–552
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parving, H.H., Larsen, M., Hommel, E. et al. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32, 440–444 (1989). https://doi.org/10.1007/BF00271264
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00271264